Regeneron to invest $100 million in it’s Limerick facility

Regeneron, one of the fastest-growing companies in the global biotechnology industry, today announced further expansion of its Limerick Industrial Operations and Product Supply (IOPS) bioprocessing campus with an additional 300 jobs and investment of $100 million, bringing the total expected employment at the site to 800 people and total investment to $750 million. The project is supported by the government through IDA Ireland. 

The additional $100 million investment will support the construction of a number of manufacturing suites to increase drug substance production capacity and enable the company to meet demand for its life-transforming medicines for patients with serious diseases.

Regeneron’s 400,000 square foot, state-of-the-art production facility in Limerick is the largest scale bulk biologics production facility in Ireland and one of the largest biologic production operations in the world.

Source: IDA Ireland